ME Therapeutics Holdings Inc. (CSE:METX)
Canada · Delayed Price · Currency is CAD 1.990
0.00 (0.00%)
At close: Jun 29, 2026
ME Therapeutics Holdings Market Cap
ME Therapeutics Holdings has a market cap or net worth of CAD 59.8 million as of July 1, 2026. Its market cap has decreased by -12.40% in one year.
Market Cap
59.80M
Enterprise Value
59.29M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.99
Market Cap Chart
Since October 12, 2023, ME Therapeutics Holdings's market cap has increased from 14.43M to 59.80M, an increase of 314.37%. That is a compound annual growth rate of 68.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 59.80M | -50.25% |
| Dec 17, 2025 | 120.20M | 19.29% |
| Dec 30, 2024 | 100.76M | 256.37% |
| Dec 29, 2023 | 28.27M | 95.92% |
| Oct 12, 2023 | 14.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Helix BioPharma | 110.75M |
| Eastwood Bio-Medical Canada | 68.20M |
| Telescope Innovations | 62.22M |
| Sernova Biotherapeutics | 52.87M |
| NurExone Biologic | 51.55M |
| MedMira | 49.12M |
| Microbix Biosystems | 40.64M |
| Defence Therapeutics | 37.89M |